TWO SIGMA ADVISERS, LP - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 58 filers reported holding CTI BIOPHARMA CORP in Q3 2021. The put-call ratio across all filers is 2.10 and the average weighting 0.3%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2022$6,169,668
+12.3%
1,026,567
+8.7%
0.02%
+6.2%
Q3 2022$5,495,000
-8.1%
944,113
-5.7%
0.02%
-5.9%
Q2 2022$5,977,000
+35.7%
1,001,113
+6.1%
0.02%
+41.7%
Q1 2022$4,406,000
+218.4%
943,413
+69.0%
0.01%
+300.0%
Q4 2021$1,384,000
-56.6%
558,113
-48.4%
0.00%
-62.5%
Q3 2021$3,191,000
+8.9%
1,081,613
-7.7%
0.01%0.0%
Q2 2021$2,931,000
+93.6%
1,172,213
+125.3%
0.01%
+100.0%
Q1 2021$1,514,000
+321.7%
520,213
+366.1%
0.00%
+300.0%
Q4 2020$359,000
-24.7%
111,613
-49.7%
0.00%0.0%
Q3 2020$477,000
+345.8%
221,983
+141.6%
0.00%
Q2 2020$107,000
+25.9%
91,883
-1.1%
0.00%
Q1 2020$85,000
-42.6%
92,883
-0.9%
0.00%
Q4 2019$148,000
+57.4%
93,683
-16.8%
0.00%
Q3 2019$94,000
-3.1%
112,583
-0.5%
0.00%
Q2 2019$97,000
-12.6%
113,183
-1.1%
0.00%
Q1 2019$111,000
+30.6%
114,483
-0.9%
0.00%
Q4 2018$85,000
-61.2%
115,483
+14.0%
0.00%
-100.0%
Q3 2018$219,000
-54.6%
101,283
+4.5%
0.00%0.0%
Q2 2018$482,00096,8830.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 6,535,674$27,449,8319.21%
Bleichroeder LP 3,893,730$16,353,6663.49%
AIGH Capital Management LLC 2,100,000$8,820,0003.25%
Ally Bridge Group (NY) LLC 550,000$2,310,0003.03%
Ghost Tree Capital, LLC 2,000,000$8,400,0002.48%
Bain Capital Life Sciences Investors, LLC 4,702,996$19,7532.47%
Altium Capital Management LP 850,000$3,570,0001.98%
Parkman Healthcare Partners LLC 1,753,630$7,365,2461.60%
BVF INC/IL 8,813,021$37,014,6881.35%
Sio Capital Management, LLC 526,239$2,210,2041.09%
View complete list of CTI BIOPHARMA CORP shareholders